(Q46716712)

24 December 2017

title

IL-12 reverses the suppressive effect of the CD40 ligand blockade on experimental autoimmune encephalomyelitis (EAE). (English)

1 reference

24 December 2017

experimental autoimmune encephalomyelitis

main subject

1 reference

1

1 reference

24 December 2017

author name string

Hilliard B

2

1 reference

24 December 2017

Wysocka M

3

1 reference

24 December 2017

Ventura ES

4

1 reference

24 December 2017

Bhopale MK

5

1 reference

24 December 2017

Trinchieri G

6

1 reference

24 December 2017

Rostami AM

7

1 reference

24 December 2017

language of work or name

1 reference

1 December 1999

1 reference

24 December 2017

Journal of the Neurological Sciences

number of pages

5

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

24 December 2017

volume

171

1 reference

24 December 2017

issue

1

1 reference

24 December 2017

page(s)

60-64

1 reference

24 December 2017

The CD40 ligand. At the center of the immune universe?

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900249-X

CD40 ligand expression is defective in a subset of patients with common variable immunodeficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900249-X

Impairment of antigen-specific T-cell priming in mice lacking CD40 ligand

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900249-X

Disruption of CD40-CD40 ligand interactions results in an enhanced susceptibility to Leishmania amazonensis infection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900249-X

CD40 ligand-transduced co-stimulation of T cells in the development of helper function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900249-X

Studies on the interdependence of gp39 and B7 expression and function during antigen-specific immune responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900249-X

Activated T cells induce interleukin-12 production by monocytes via CD40-CD40 ligand interaction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900249-X

Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900249-X

CD40/CD40 ligand interactions are required for T cell-dependent production of interleukin-12 by mouse macrophages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900249-X

High level IL-12 production by murine dendritic cells: upregulation via MHC class II and CD40 molecules and downregulation by IL-4 and IL-10.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900249-X

Prevention of collagen-induced arthritis with an antibody to gp39, the ligand for CD40

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900249-X

Therapeutic potential for blockade of the CD40 ligand, gp39.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900249-X

The T lymphocyte in experimental allergic encephalomyelitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900249-X

T-cell subsets in autoimmunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900249-X

Interleukin-12 and its role in the generation of TH1 cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900249-X

Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900249-X

Prevention of experimental autoimmune encephalomyelitis by antibodies against interleukin 12.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900249-X

Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900249-X

CD40-CD40 ligand interactions in experimental allergic encephalomyelitis and multiple sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900249-X

CD40L blockade prevents autoimmune encephalomyelitis and hampers TH1 but not TH2 pathway of T cell differentiation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900249-X

Requirement for CD40 ligand in costimulation induction, T cell activation, and experimental allergic encephalomyelitis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900249-X

Interleukin-12 is required for interferon-gamma production and lethality in lipopolysaccharide-induced shock in mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900249-X

Tumor necrosis factor alpha and lymphotoxin alpha are not required for induction of acute experimental autoimmune encephalomyelitis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900249-X

In vivo CD40-gp39 interactions are essential for thymus-dependent humoral immunity. II. Prolonged suppression of the humoral immune response by an antibody to the ligand for CD40, gp39.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900249-X

Blockade of CD28/B7-1 interaction prevents epitope spreading and clinical relapses of murine EAE

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900249-X

B7 and interleukin 12 cooperate for proliferation and interferon gamma production by mouse T helper clones that are unresponsive to B7 costimulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900249-X

Interleukin 12 synergizes with B7/CD28 interaction in inducing efficient proliferation and cytokine production of human T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900249-X

An antibody to lymphotoxin and tumor necrosis factor prevents transfer of experimental allergic encephalomyelitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900249-X

Anti?tumor necrosis factor therapy abrogates autoimmune demyelination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900249-X

Blocking the CD40L-CD40 interaction in vivo specifically prevents the priming of T helper 1 cells through the inhibition of interleukin 12 secretion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900249-X

B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune disease therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900249-X

Increased interleukin 12 production in progressive multiple sclerosis: induction by activated CD4+ T cells via CD40 ligand

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900249-X

An interleukin (IL)-10/IL-12 immunoregulatory circuit controls susceptibility to autoimmune disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900249-X

Cytokine production in the central nervous system of Lewis rats with experimental autoimmune encephalomyelitis: dynamics of mRNA expression for interleukin-10, interleukin-12, cytolysin, tumor necrosis factor α and tumor necrosis factor β

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900249-X

Leishmania pifanoi amastigote antigens protect mice against cutaneous leishmaniasis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900249-X

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0022-510X(99)00249-X

1 reference

24 December 2017

PubMed ID

10567051

1 reference

24 December 2017